Skip to main content

Table 1 Demographic, dialysis and transplant characteristics of patients in treatment groups

From: The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients

Variables

CsA Group

(n = 60)

Tac Group

(n = 68)

p value

Transplant age (years)

44 (20–64)

36 (19–62)

0.020

Gender (female/male)

32/28

37/31

0.903

Primary etiology n (%)

  Diabetes mellitus

11 (18.3)

1 (1.5)

 < 0.001

  Hypertension

25 (41.7)

32 (47.1)

 > 0.05

  Glomerulonephritis

2 (3.3)

11 (16.2)

 > 0.05

  Polycystic kidney diseases

5 (8.3)

3 (4.4)

 > 0.05

  Nephrolithiasis

4 (6.7)

1 (1.5)

 > 0.05

  Obstructive nephropathy

2 (3.3)

6 (8.8)

 > 0.05

  Amyloidosis

1 (1.7)

2 (2.9)

 > 0.05

  Unknown etiology

10 (16.7)

12 (17.6)

 > 0.05

Dialysis modality

  Pre-emptive

8 (13.3)

14 (20.6)

0.759

  Hemodialysis

38 (63.3)

38 (55.9)

  Peritoneal dialysis

8 (13.3)

9 (13.2)

  Both dialysis

6 (10.0)

7 (10.3)

Dialysis duration (month)

66 (0:220)

53 (0:228)

0.851

Transplant type (living/deceased)

27/33

34/34

0.319

Donor age (years)

49 (22–80)

50 (17–85)

0.822

Cold ischemia time (hour)

9.5 (1:20)

4.5 (1:16)

0.439

HLA mismatch

3.13 ± 1.19

3.42 ± 1.05

0.144

Induction treatment (ATG/basiliximab)

2/58

13/55

0.006

Immunosuppressive regimen n (%)

  

0.889

  CsA + EC-MPS + prednisolone

21 (35)

-

 

  CsA + MMF + prednisolone

39 (65)

-

  Tac + EC-MPS + prednisolone

-

23 (33.8)

  Tac + MMF + prednisolone

-

45 (66.2)

Pre-operative steroid use n (%)

5 (8.3)

11 (16.2)

0.284

Cumulative dose of prednisolone (mg)

11,187 ± 1,529

10,884 ± 1,526

0.289

Cytomegalovirus history n (%)

17 (28.3)

18 (26.5)

0.845

BK virus n (%)

8 (13.3)

6 (8.8)

0.572

Acute rejection n (%)

4 (6.7)

9 (13.2)

0.220

Delayed graft function n (%)

19 (31.7)

17 (25)

0.403

  1. Data were expressed as mean ± SD (standard deviation) or n (%). CsA: cyclosporine A, Tac: tacrolimus, ATG: antithymocyte globulin, EC-MPS: enteric-coated mycophenolate sodium, MMF: mycophenolate mofetil